rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1997-5-12
|
pubmed:abstractText |
Rifampicin is a potent inducer of the hepatic microsomal enzyme system. However, the drug has been shown to cause clinically important interactions with many drugs. This study was designed to test the interaction of rifampicin with the oral hypoglycaemic agent glibenclamide.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0970-258X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11-2
|
pubmed:dateRevised |
2009-7-30
|
pubmed:meshHeading |
pubmed-meshheading:9069698-Adult,
pubmed-meshheading:9069698-Aged,
pubmed-meshheading:9069698-Antibiotics, Antitubercular,
pubmed-meshheading:9069698-Blood Glucose,
pubmed-meshheading:9069698-Diabetes Mellitus, Type 2,
pubmed-meshheading:9069698-Drug Interactions,
pubmed-meshheading:9069698-Female,
pubmed-meshheading:9069698-Glyburide,
pubmed-meshheading:9069698-Humans,
pubmed-meshheading:9069698-Hypoglycemic Agents,
pubmed-meshheading:9069698-Male,
pubmed-meshheading:9069698-Middle Aged,
pubmed-meshheading:9069698-Rifampin
|
pubmed:articleTitle |
Drug interaction: rifampicin and glibenclamide.
|
pubmed:affiliation |
Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|